Leah Belazarian to Retrospective Studies
This is a "connection" page, showing publications Leah Belazarian has written about Retrospective Studies.
Connection Strength
0.350
-
Pagani K, Plumptre I, Amin S, Lal K, Wiss K, Belazarian L. Low rates of neurological abnormalities in patients with pigmentary mosaicism: A retrospective cohort study from a tertiary dermatology center. Pediatr Dermatol. 2023 May-Jun; 40(3):446-451.
Score: 0.093
-
Leonard N, Droms R, Lal K, Wiss K, Aidlen JT, Silvestri D, Belazarian L. Utility of routine patch testing prior to surgical repair of pectus excavatum: A multidisciplinary experience via retrospective review at a single tertiary care center. Pediatr Dermatol. 2021 Nov; 38(6):1510-1514.
Score: 0.085
-
Rork JF, McCormack L, Lal K, Wiss K, Belazarian L. Dermatologic conditions in Down syndrome: A single-center retrospective chart review. Pediatr Dermatol. 2020 Sep; 37(5):811-816.
Score: 0.077
-
Neale H, Plumptre I, Belazarian L, Wiss K, Hawryluk EB. Central nervous system magnetic resonance imaging abnormalities and neurologic outcomes in pediatric patients with congenital nevi: A 10-year multi-institutional retrospective study. J Am Acad Dermatol. 2022 11; 87(5):1060-1068.
Score: 0.022
-
Tripathi R, Mazmudar RS, Knusel KD, Ezaldein HH, Belazarian LT, Bordeaux JS, Scott JF. Impact of congenital cutaneous hemangiomas on newborn care in the United States. Arch Dermatol Res. 2021 Oct; 313(8):641-651.
Score: 0.020
-
Bronckers IMGJ, Paller AS, West DP, Lara-Corrales I, Tollefson MM, Tom WL, Hogeling M, Belazarian L, Zachariae C, Mah? E, Siegfried E, Blume-Peytavi U, Szalai Z, Vleugels RA, Holland K, Murphy R, Puig L, Cordoro KM, Lambert J, Alexopoulos A, Mrowietz U, Kievit W, Seyger MMB. A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic Agents. JAMA Dermatol. 2020 04 01; 156(4):384-392.
Score: 0.019
-
Prindaville B, Belazarian L, Levin NA, Wiss K. Pityrosporum folliculitis: A retrospective review of 110 cases. J Am Acad Dermatol. 2018 03; 78(3):511-514.
Score: 0.016
-
Bronckers IMGJ, Seyger MMB, West DP, Lara-Corrales I, Tollefson M, Tom WL, Hogeling M, Belazarian L, Zachariae C, Mah? E, Siegfried E, Philipp S, Szalai Z, Vleugels RA, Holland K, Murphy R, Baselga E, Cordoro K, Lambert J, Alexopoulos A, Mrowietz U, Kievit W, Paller AS. Safety of Systemic Agents for the Treatment of Pediatric Psoriasis. JAMA Dermatol. 2017 11 01; 153(11):1147-1157.
Score: 0.016